Methods of Creating and Screening DNA-Encoded Libraries
Summary
The USPTO granted Patent US12606817B2 to X-Chem, Inc. (inventor: Richard W. Wagner) for methods of creating and screening DNA-encoded libraries for drug discovery applications. The patent contains 17 claims covering synthesis and screening methodologies that link functional moieties to initiator oligonucleotides for target binding identification. The filing date was June 19, 2020, with application number 16906626.
What changed
X-Chem, Inc. received USPTO Patent US12606817B2 for methods of identifying compounds that bind to biological targets using DNA-encoded libraries. The patented methods involve synthesizing libraries where compounds contain functional moieties with diversity positions, operatively linked to initiator oligonucleotides that identify compound structures. This is a standard biotech patent grant strengthening X-Chem's intellectual property position in DNA-encoded library technology.
Competitors developing DNA-encoded library screening methods should conduct freedom-to-operate analyses to assess potential infringement exposure. Pharmaceutical and biotechnology companies utilizing these techniques may need to evaluate licensing requirements or design-around strategies for drug discovery programs leveraging similar approaches.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods of creating and screening DNA-encoded libraries
Grant US12606817B2 Kind: B2 Apr 21, 2026
Assignee
X-Chem, Inc.
Inventors
Richard W. Wagner
Abstract
The present invention features a number of methods for identifying one or more compounds that bind to a biological target. The methods include synthesizing a library of compounds, wherein the compounds contain a functional moiety having one or more diversity positions. The functional moiety of the compounds is operatively linked to an initiator oligonucleotide that identifies the structure of the functional moiety.
CPC Classifications
C07H 21/00 C12N 15/1065 C12N 15/1068 C12Q 1/6809 C40B 20/04 C40B 40/04 C40B 40/06 C40B 40/08 C40B 50/06 C40B 70/00
Filing Date
2020-06-19
Application No.
16906626
Claims
17
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.